Beyond PACIFIC: Uncharted Waters

Affiliations

¹ Department of Cellular and Radiation Oncology, The University of Chicago, Chicago, Illinois; University of Chicago Comprehensive Cancer Center, Chicago, Illinois.
² University of Chicago Comprehensive Cancer Center, Chicago, Illinois; Section of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago, Illinois. Electronic address: evokes@medicine.bsd.uchicago.edu.

Free article

Editorial

Aditya Juloori et al. J Thorac Oncol. 2021 May.

Free article

. 2021 May;16(5):715-718.

doi: 10.1016/j.jtho.2021.02.006.

¹ Department of Cellular and Radiation Oncology, The University of Chicago, Chicago, Illinois; University of Chicago Comprehensive Cancer Center, Chicago, Illinois.
² University of Chicago Comprehensive Cancer Center, Chicago, Illinois; Section of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago, Illinois. Electronic address: evokes@medicine.bsd.uchicago.edu.

No abstract available

Comment on

Four-Year Survival With Durvalumab After Chemoradiotherapy in Stage III NSCLC-an Update From the PACIFIC Trial.
Faivre-Finn C, Vicente D, Kurata T, Planchard D, Paz-Ares L, Vansteenkiste JF, Spigel DR, Garassino MC, Reck M, Senan S, Naidoo J, Rimner A, Wu YL, Gray JE, Özgüroğlu M, Lee KH, Cho BC, Kato T, de Wit M, Newton M, Wang L, Thiyagarajah P, Antonia SJ. Faivre-Finn C, et al. J Thorac Oncol. 2021 May;16(5):860-867. doi: 10.1016/j.jtho.2020.12.015. Epub 2021 Jan 19. J Thorac Oncol. 2021. PMID: 33476803 Clinical Trial.